Pérez LB, Fernández SLT, Díaz CJM

Language: Spanish
References: 24
Page: 1-14
PDF size: 391.74 Kb.

ABSTRACT

Introduction: The managment of Crohn’s disease consists in symptoms control for achieving clinical remission. When this is not accomplished or complications reappear, surgical treatment may be necessary.
Objective: To assess the outcomes of surgical treatment of patients with complicated Crohn's disease.
Method: An ambispective, descriptive and longitudinal study was carried out with a sample of twenty patients with complicated Crohn's disease who attended the general surgery and gastroenterology consultation at Hermanos Ameijeiras Clinical Surgical Hospital and the Gastroenterology Institute, in the period from January 2010 to May 2019. All demographic variables were collected, as well as the results of hemochemical, imaging and endoscopic studies.
Results: The highest incidence of complications from Crohn's disease was observed in patients over fifty years of age and with an evolution time between one and ten years. Fistula and plastron were the main causes for surgical treatment. The laparoscopic approach showed advantages over the conventional one. Hydromineral imbalance and surgical site infection were the main postoperative complications, with low mortality.
Conclusions: Elective, planned and sequential surgical treatment of patients with complicated Crohn's disease offers good outcomes. It is possible to use the video-assisted approach, with encouraging outcomes in selected patients.

REFERENCES

1. Davis KG. Crohn's Disease of the Foregut. Surg Clin N Am. 2015;95(6):1183-93.

2. Arin Letamendia A, Borda Celaya F, Burusco Paternain MJ, Prieto Martínez C, Martínez Echeverria A, Elizalde Apestegui I, et al. High incidence rates of inflammatory bowel disease in Navarra. Results of a prospective, population-based study. Gastroenterol Hepatol. 2008;3:111-6.

3. Siew C, Yun Shi H, Hamidi N, Underwood F, Tang W, Benchimol E I, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2017;390: 2769-78.

4. Beaugerie L, Seksik P, Nion-Larmurier I, Gendre JP, Cosnes J. Predictors of Crohn's disease. Gastroenterology. 2006;3:650-6.

5. Kaplan GG, Ng SC. Understanding and preventing the global increase of inflammatory bowel disease. Gastroenterology. 2017;152:313-21.

6. United Nations. Standard country or area codes for statistical use (M49). 1999 [acceso 01/06/2017]. Disponible en: https://unstats.un.org/unsd/methodology/m49/

7. Lichtenstein GR, Hanauer SB, Sandborn W. Practice Parameters Committee of the American College of Gastroenterology. Management of Crohn's disease in adults. Am J Gastroenterol. 2001;96(3):635-43.

8. Nos-Mateu P, Aguas-Peri M. Enfermedades del tubo digestivo: enfermedad inflamatoria del tubo digestivo. Programa de formación médica continuada. 2012;11(5):275-83.

9. Paredes J, Otoya G, Mestanza AL, Lazo L, Acuña K, Arenas JL, et al. Características epidemiológicas y clínicas de la enfermedad inflamatoria intestinal en un hospital de referencia de Lima-Perú. Perú: Rev Gastroenterol. 2016;36:209-18.

10. Imigo G, Molina P, Álvarez-Lobos M, Quintana V, Klaassen L, Torres M, et al. Colitis de Crohn: resultados del tratamiento quirúrgico y evolución alejada. Revista médica de Chile. 2018;146(2):183-9.

11. Reyes GA, Gil FL, Carvajal GD, Bernardo C, Aponte DM, González CA, et al. Enfermedad inflamatoria intestinal: características de fenotipo y tratamiento en un hospital universitario de Bogotá, Colombia. Rev Colomb Gastroenterol. 2018;33(2):117-26.

12. Alhagamhmad M, Leach S, Lemberg D, Day A. Changing paterns in the epidemiology of Crohn disease. Journal of GHR. 2015;4(11):1805-9.

13. Hano García O, Andrade Gomes S, Villa Jiménez O, González Fabián L, Wood Rodríguez L. Caracterización de pacientes con enfermedad de Crohn atendidos en el Instituto de Gastroenterología de Cuba. Rev Cub Invest Biomed. 2014;33(3):253-67.

14. Stepaniuk P, Bernstein CN, Nugent Z, Singh H. Characterization of inflammatory bowel disease in hospitalized elderly patients in a large central Canadian health region. Can J Gastroenterol Hepatol. 2015;29:274-8.

15. Hoffmann M, Siebrasse D, Schlöricke E, Bouchard R, Keck T, Benecke C, et al. Long-term outcome of laparoscopic and open surgery in patients with Crohn's disease. Open Access Surgery. 2017;10:45.

16. Sevim Y, Akyol C, Aytac E, Baca B, Bulut O, Remzi FH, et al. Laparoscopic surgery for complex and recurrent Crohn's disease. World journal of gastrointestinal endoscopy. 2017;9(4):149.

17. Fumery M, Seksik P, Auzolle C, Munoz-Bongrand N, Gornet JM, Boschetti G, et al. 2017. Postoperative complications after ileocecal resection in Crohn's disease: a prospective study from the REMIND group. The American journal of gastroenterology. 2017;112(2):337.

18. Wolters FL, Russel MG, Sijbrandij J. Phenotype at diagnosis predicts recurrence rates in Crohn's disease. Gut. 2006;55(8):1124-30.

19. Solberg IC, Vatn MH, Høie O. Clinical course in Crohn's disease: results of a Norwegian population-based ten-year follow-up study. Clin Gastroenterol Hepatol. 2010;5(12):1430-8.

20. Álvarez BC. Enfermedad de Crohn. Revista Salud y Ciencias. 2017;1(1):3-4.

21. Marteau P, Allez M, Jian R. Enfermedad de Crohn. EMC-Tratado de Medicina. 2013;17(4):1-8.

22. Eglinton TW, Barclay ML, Gearry RB, Frizelle FA. The spectrum of perianal Crohn's disease in a population-based cohort. Dis Colon Rectum. 2012;55(7):773-7.

23. Guo D, Gong J, Cao L, Wei Y, Guo Z, Zhu W, et al. Laparoscopic surgery can reduce postoperative edema compared with open surgery. Gastroenterol Res Pract; 2016.

24. Patel SV, Patel SV, Ramagopalan SV, Ott MC. Laparoscopic surgery for Crohns disease: a meta-analysis of perioperative complications and long term outcomes compared with open surgery. BMC Suergery. 2013;13(1):13-4.